Recent studies in certain cancer types, e.g., gastric cancer, oesophageal cancer, and head and neck squamous cell carcinomas, have indicated the involvement of CSMD1 in response to immunotherapy. This evidence concerns the gene CSMD1 and head and neck squamous cell carcinoma.